Current portfolio

AM-Pharma

Dutch clinical stage biopharmaceutical company developing a treatment for acute kidney injury.

  • Sector
    Healthcare
  • Country
    Netherlands
  • Fund
    LSP 6
  • Entry
    2019
  • Web
Logo

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
A purpose-driven global investment organization
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180